29 "Pancreatic cancer" clinical trials found.
-
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Adjuvant Chemotherapy in Patients with Resected Pancreatic Cancer and a Pathogenic BRCA1 BRCA2 or PALB2 Mutation
This phase II trial investigates how well the addition of olaparib following completion of surgery and chemotherapy works in treating patients with pancreatic cancer that ...Phase
Interventional
-
A Phase 2 Open-label Study of VS-7375 an Oral KRAS G12D (ON/OFF) Inhibitor as Monotherapy and with Cetuximab in Patients with Metastatic KRAS G12D-Mutated Pancreatic Cancer (TARGET-D 201)
This is a Phase 2, open-label study for adults with metastatic pancreatic cancer that has a KRAS G12D gene mutation. The study is testing an ...
Phase
Interventional
-
NRG-GI011 A Phase III Randomized Trial of Dose Escalated Radiation in Locally Advanced Pancreas Cancer (LAPC) Patients (LAP100)
NRG-GI011, A Phase III Randomized Trial of Dose Escalated Radiation in Locally Advanced Pancreas Cancer (LAPC) Patients (LAP100)Phase
Interventional
-
EXtending outcomes for PAncreas cancer patients with Nominal oligometastatic Disease (EXPAND): A randomized phase III trial
This is a study to determine whether, in patients with oligometastatic pancreatic ductal adenocarcinoma, metastasis-directed therapy to all sites of disease confers a benefit in ...Phase
Interventional
-
A Phase 1/2 Study to Evaluate the Safety and Efficacy of MK-2870 Monotherapy or in Combination With Other Anticancer Agents in Gastrointestinal Cancers
This study is testing a new cancer treatment called MK-2870 to see if it has few side effects and works well for patients with certain ...Phase
Interventional
-
An Open-label Phase 1a/b Multicenter Study of ZL-6201 to Evaluate Safety Tolerability Pharmacokinetics and Preliminary Efficacy in Participants with Sarcoma and Selected Solid Tumors
This is a Phase 1 study testing a new medicine called ZL-6201 (an experimental antibody-drug conjugate - ADC) in patients with advanced bone sarcomas, soft tissue ...
Phase
Interventional
-
A Phase 3 Randomized Open-Label Study of Atebimetinib in Combination with the Modified Gemcitabine and nab-Paclitaxel Regimen Versus the Standard Gemcitabine and nab-Paclitaxel Regimen for the Treatment of Patients with Metastatic Pancreatic Ductal Adenocarcinoma Cancer (MAPKeeper 301)
This is a Phase 3 study testing how safe and effective a new drug combination is for people with metastatic pancreatic cancer (PDAC) who have ...
Phase
Interventional
-
A Randomized Double-Blind Phase 3 Study of Chemotherapy With or Without INCB161734 in Previously Untreated KRAS G12D Mutated Metastatic Pancreatic Ductal Adenocarcinoma (DAWN-303)
This is a Phase 3 study for people with metastatic pancreatic ductal adenocarcinoma (PDAC), the most common type of pancreatic cancer. To join the study ...
Phase
Interventional
-
Phase
Interventional
-
A Phase 1a/1b Trial of LY3962673 in Participants with KRAS G12D-Mutant Solid Tumors
This study is testing the tolerability, effectiveness, and potential for few side effects of the drug LY3962673 in patients with advanced solid tumors that have ...
Phase
Interventional
